Trial intelligence / Profile preview

Effect of Roflumilast on Airway Blood Flow in COPD

NCT02097992Phase 2Completed

Sponsor
University of Miami
Start
Feb 2013
Primary completion
Jul 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of roflumilast in chronic obstructive pulmonary disease (COPD), sponsored by University of Miami. Started Feb 2013; status: completed.

02

Drugs

roflumilast
03

Conditions

chronic obstructive pulmonary disease (COPD)

Beyond the preview

Go deeper on NCT02097992.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02097992.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call